Burcon Nutrascience Corporation
BU.TO
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 594.10K | 530.20K | 259.30K | 247.30K | 29.80K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 594.10K | 530.20K | 259.30K | 247.30K | 29.80K |
| Cost of Revenue | 2.51M | 1.67M | 1.53M | 1.28M | 412.90K |
| Gross Profit | -1.91M | -1.14M | -1.27M | -1.04M | -383.00K |
| SG&A Expenses | 540.00K | 519.00K | 584.90K | 533.00K | 615.30K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.99M | 2.44M | 2.37M | 2.04M | 1.38M |
| Operating Income | -2.40M | -1.91M | -2.11M | -1.79M | -1.35M |
| Income Before Tax | -2.87M | -2.56M | -2.61M | -2.51M | -1.57M |
| Income Tax Expenses | -280.40K | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.59M | -2.56M | -2.61M | -2.51M | -1.57M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.59M | -2.56M | -2.61M | -2.51M | -1.57M |
| EBIT | -2.40M | -1.91M | -2.11M | -1.79M | -1.35M |
| EBITDA | -1.63M | -1.15M | -2.07M | -1.74M | -1.32M |
| EPS Basic | -0.20 | -0.20 | -0.21 | -0.20 | -0.16 |
| Normalized Basic EPS | -0.14 | -0.13 | -0.13 | -0.12 | -0.10 |
| EPS Diluted | -0.20 | -0.20 | -0.21 | -0.20 | -0.16 |
| Normalized Diluted EPS | -0.14 | -0.13 | -0.13 | -0.12 | -0.10 |
| Average Basic Shares Outstanding | 12.84M | 12.69M | 12.69M | 12.69M | 9.84M |
| Average Diluted Shares Outstanding | 12.84M | 12.69M | 12.69M | 12.69M | 9.84M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |